The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma

R Donne, A Lujambio - Hepatology, 2023 - journals.lww.com
The liver is the sixth most common site of primary cancer in humans and the fourth leading
cause of cancer‐related death in the world. Hepatocellular carcinoma (HCC) accounts for …

Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification

S Chidambaranathan-Reghupaty, PB Fisher… - Advances in cancer …, 2021 - Elsevier
Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with
bleak outcome. According to National Cancer Institute's SEER database, the average five …

WNT as a driver and dependency in cancer

MJ Parsons, T Tammela, LE Dow - Cancer discovery, 2021 - AACR
The WNT signaling pathway is a critical regulator of development and adult tissue
homeostasis and becomes dysregulated in many cancer types. Although hyperactivation of …

From NASH to HCC: current concepts and future challenges

QM Anstee, HL Reeves, E Kotsiliti, O Govaere… - Nature reviews …, 2019 - nature.com
Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and
metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity …

Hepatocellular carcinoma: old friends and new tricks

E Kim, P Viatour - Experimental & molecular medicine, 2020 - nature.com
Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer and a leading
cause of cancer-related deaths worldwide. Ninety percent of HCC cases arise from cirrhosis …

Advances in molecular classification and precision oncology in hepatocellular carcinoma

S Rebouissou, JC Nault - Journal of hepatology, 2020 - Elsevier
Hepatocellular carcinoma (HCC) arises from hepatocytes through the sequential
accumulation of multiple genomic and epigenomic alterations resulting from Darwinian …

[HTML][HTML] Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma

Q Gao, H Zhu, L Dong, W Shi, R Chen, Z Song… - Cell, 2019 - cell.com
We performed the first proteogenomic characterization of hepatitis B virus (HBV)-related
hepatocellular carcinoma (HCC) using paired tumor and adjacent liver tissues from 159 …

Convergent somatic mutations in metabolism genes in chronic liver disease

SWK Ng, FJ Rouhani, SF Brunner, N Brzozowska… - Nature, 2021 - nature.com
The progression of chronic liver disease to hepatocellular carcinoma is caused by the
acquisition of somatic mutations that affect 20–30 cancer genes,,,,,,–. Burdens of somatic …

Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

L Broutier, G Mastrogiovanni, MMA Verstegen… - Nature medicine, 2017 - nature.com
Human liver cancer research currently lacks in vitro models that can faithfully recapitulate
the pathophysiology of the original tumor. We recently described a novel, near-physiological …

Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease

C Lebeaupin, D Vallée, Y Hazari, C Hetz, E Chevet… - Journal of …, 2018 - Elsevier
The global epidemic of obesity has been accompanied by a rising burden of non-alcoholic
fatty liver disease (NAFLD), with manifestations ranging from simple steatosis to non …